Development of Leptomeningeal Carcinomatosis During a Marked Response of Brain Metastases to Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx700
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
Elsevier BV